中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
GALUNISERTIB中间体 |
4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrile |
924898-13-5 |
C22H17N5 |
|
G9A和PRC2抑制剂(BRD9539) |
2-benzamido-1-(3-phenylpropyl)-1H-1,3-benzodiazole-5-carboxylic acid |
1374601-41-8 |
C24H21N3O3 |
|
Fagomine; 桑叶生物碱; (2R,3R,4R)-2-羟甲基哌啶-3,4-二醇 |
D-fagomine |
53185-12-9 |
C6H13NO3 |
|
FRAX1036游离态 |
Frax1036 |
1432908-05-8 |
C28H32ClN7O |
|
FR180204,一种ATP-竞争性的选择性的ERK抑制剂 |
FR180204 |
865362-74-9 |
C18H13N7 |
|
FR167653硫酸盐 |
FR167653 |
158876-66-5 |
C24H18FN5O2*H2O4S |
|
FP-生物素 |
FP-biotin |
259270-28-5 |
C27H50FN4O5PS |
|
FMOC-L-1,2,3,4-四氢-Β-咔啉-3-羧酸 |
N-Fmoc-Tpi-OH |
204322-23-6 |
C27H22N2O4 |
|
FLUO3五胺盐 |
Fluo-3 (pentaammonium) |
—— |
C36H45Cl2N7O13 |
|
FGFR抑制剂(NVP-BGJ398) |
BGJ398 |
872511-34-7 |
C26H31Cl2N7O3 |
|
FGFR1酪氨酸激酶抑制剂(PD-166866) |
PD 166866 |
192705-79-6 |
C20H24N6O3 |
|
FCLA自由酸[化学发光试剂] |
2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-5-[({2-[4-(2-methyl-3-oxo-3,7-dihydroimidazo[1,2-a]pyrazin-6-yl)phenoxy]ethyl}carbamothioyl)amino]benzoic acid |
133118-06-6 |
C36H27N5O7S |
|
FAVIPIRAVIR杂质14 |
3-chloro-6-fluoro-2-pyrazinecarbonitrile |
356783-49-8 |
C5HClFN3 |
|
FAM炔烃6异构体 |
6-(prop-2-yn-1-yl)carbamoylfluorescein |
478801-49-9 |
C24H15NO6 |
|
FAM叠氮化物,6-异构体 |
N-(3-azidoprop-1-yl)fluoresceinyl-6-carboxamide |
1386385-76-7 |
C24H18N4O6 |
|
F1-20蛋白质 |
3-Ethyl-2-methylquinoxalin-5-amine |
126987-75-5 |
C11H13N3 |
|
F-氟离子探针(叠氮) |
1-(3',6'-Bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)-3-phenylurea |
957493-98-0 |
C33H33N5O3 |
|
Ethyl 5-氨基-4-氰基-3-甲基-2-噻吩羧酸乙酯 |
ethyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate |
23903-46-0 |
C9H10N2O2S |
|
Esomeprazole镁盐水合物 |
(S)-Omeprazole magnesium;(-)-Omeprazole magnesium |
668985-31-7 |
C34H38MgN6O7S2 |
|
Egenine; (6R,8S)-6,8-二氢-6-[(5S)-5,6,7,8-四氢-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基]呋喃并[3,4-e]-1,3-苯并二氧杂环戊烯-8-醇 |
(+)-egenine |
6883-44-9 |
C20H19NO6 |
|
Eg5抑制剂VII |
6-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-quinolin-2-one |
912953-25-4 |
C16H12F3NO |
|
Eg5抑制剂IV,VS-83 |
Eg5 Inhibitor IV, VS-83 |
909250-29-9 |
C14H11FN2OS |
|
EZH2甲基转移酶抑制剂(GSK126) |
GSK-126 |
1346574-57-9 |
C31H38N6O2 |
|
EVACETRAPIB中间体 |
methyl 7,9-dimethyl-5-oxo-2,3,4,5-tetra-hydro-1H-benzo[b]azepine-1-carboxylate |
1259393-27-5 |
C14H17NO3 |
|
ETHYLONE盐酸盐 |
bk-MDEA (hydrochloride) |
1454266-19-3 |
C12H16ClNO3 |
|
ETHYL4,6-O-BENZYLIDENE-2-DEOXY-2-PHTHALIMIDO-1-THIO-Β-D-GLUCOPYRANOSIDE乙基4,6-O-亚苄基-2-脱氧-2-邻苯二甲酰亚氨基-1-硫代-Β-D-吡喃葡萄糖苷 |
ethyl 4,6-O-benzylidene-2-deoxy-2-N-phthalamido-1-thio-β-Dglucopyranoside |
99409-33-3 |
C23H23NO6S |
|
ETHYL 5-硝基-2-吡啶乙基甲苯 |
ethyl 5-nitropicolinate |
30563-98-5 |
C8H8N2O4 |
|
ERK抑制剂II,阴性对照 |
ERK Inhibitor II, Negative Control |
1177970-73-8 |
C18H12N6O |
|
EPZ005687抑制剂 |
EPZ005687 |
1396772-26-1 |
C32H37N5O3 |
|
ENT-甲磺酸帕珠沙星 |
ent-Pazufloxacin Mesylate |
677004-96-5 |
C17H19FN2O7S |
|
ENT-他达拉非 |
(+/-) cis-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
629652-72-8 |
C22H19N3O4 |
|
EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈 |
tepotinib |
1100598-32-0 |
C29H28N6O2 |
|
EMD 534085; N-[2-(二甲基氨基)乙基]-N'-[[(2R,4aS,5R,10bS)-3,4,4a,5,6,10b-六氢-5-苯基-9-(三氟甲基)-2H-吡喃并[3,2-c]喹啉-2-基]甲基]脲 |
EMD 534085 |
858668-07-2 |
C25H31F3N4O2 |
|
EIPA盐酸盐 |
ethylisopropyl amiloride hydrochloride |
1345839-28-2 |
C11H18ClN7O*ClH |
|
EGFR-IN-9(化合物8) |
N-{3-[4-(2-hydroxy-1-phenylethylamino)-6-phenylfuro[2,3-d]-pyrimidin-5-yl]phenyl}acrylamide |
1226549-39-8 |
C29H24N4O3 |
|
EED抑制剂(EEDINHIBITOR-1) |
MAK683 |
1951408-58-4 |
C20H17FN6O |
|
EBP氯代物杂质 |
5'-Chloro eltrombopag |
376592-56-2 |
C25H21ClN4O4 |
|
EAM-1试剂 |
[2-(4-nitro-2,1,3-benzoxadiazol-7-yl)aminoethyl]trimethylammonium |
287970-46-1 |
C11H16N5O3 |
|
EA671;;二噻吩[3,2-E:2,3-G]-2,1,3-苯并噻二唑 |
dithieno[3',2':3,4;2'',3'':5,6]benzo[1,2-c][1,2,5]thiadiazole |
1256138-50-7 |
C10H4N2S3 |
|
E-9-(β-硝基乙烯基)久洛尼定 |
9-(2-nitro-vinyl)-2,3,6,7-tetrahydro-1<i>H</i>,5<i>H</i>-pyrido[3,2,1-<i>ij</i>]quinoline |
101077-26-3 |
C14H16N2O2 |
|
E-2,3-环氧-1-碘辛烷 |
(2S,3R)-2-(iodomethyl)-3-pentyloxirane |
111321-50-7 |
C8H15IO |
|
E-2,3-环氧-1-碘辛烷 |
E-2,3-epoxy-1-iodooctane |
111258-65-2 |
C8H15IO |
|
E-2,2-亚乙烯基二(5-甲基苯并恶唑) |
1,2-bis(5-methylbenzoxazol-2-yl)ethylene |
17233-65-7 |
C18H14N2O2 |
|
E,E'-3,3':8,8'-二蒿本内酯 |
angelicolide |
90826-58-7 |
C24H28O4 |
|
D咪唑并n |
1-Phenyl-4,5-dimethoxy-6-pyridazon |
3295-78-1 |
C12H12N2O3 |
|
Dolutegravir中间体 |
1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid |
1335210-23-5 |
C13H17NO8 |
|
DolutegravirDL5A中间体 |
2,5-dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
1357289-08-7 |
C20H23NO8 |
|
DilC12(3)高氯酸盐(超纯) |
1,1'-Didodecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate |
75664-01-6 |
C47H73ClN2O4 |
|
DPX包埋剂 |
N,N'-4-Xylylenebis(pyridinium) |
14208-10-7 |
C18H18Br2N2 |
|
DPRE1抑制剂(DPRE1-IN-2) |
1-((6-(dimethylamino)-5-methylpyrimidin-4-yl)methyl)-N-(2-hydroxyethyl)-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide |
1615713-87-5 |
C19H24N6O2 |
|